-
Mashup Score: 0Navigating Insurance for Genetic Testing - Episode 1 of 3: Understanding Your Insurance - 10 day(s) ago
Gathering information and getting organized is the first step! This first of three episodes will help you take steps toward understanding your insurance poli…
Source: www.youtube.comCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 5Considering screening for hereditary cancer syndromes at the time of obstetrical prenatal carrier screening - 5 month(s) ago
Preconception and pregnancy represent a unique window of opportunity for women to engage with the health care system. This article explores the possibility of offering testing for cancer-associated p…
Categories: General Medicine News, Oncologists1Tweet-
This new commentary proposes several reasons why patients might consider the option to include cancer-associated pathogenic variants on obstetrical carrier screening panels. https://t.co/qudrexbdAb @OncoAlert #genetictesting https://t.co/7H9fHGGd9K
-
-
Mashup Score: 3Familial uveal melanoma and other tumors in 25 families with monoallelic germline MBD4 variants - 6 month(s) ago
AbstractBackground. Monoallelic germline MBD4 pathogenic variants were recently reported to cause a predisposition to uveal melanoma, associated with a spe
Source: academic.oup.comCategories: General Medicine News, Oncologists1Tweet-
Study reports a link between monoallelic germline MBD4 pathogenic variants and familial uveal melanoma as well as breast, renal, and colorectal tumors. #genetictesting @institut_curie Read more here: https://t.co/oWgR7a185J
-
-
Mashup Score: 1Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline Clinical Insights - 8 month(s) ago
This clinical insights article is derived from recommendations in Selection of Germline Genetic Testing Panels in Patients with Cancer: ASCO Guideline. 1 This document is based on an ASCO Guideline and is not intended to substitute for the independent professional judgment of the treating physician. Practice guidelines do not account for individual variation among patients. This article does not purport to suggest any particular course of medical treatment. Use of the guideline and thi s article are
Source: ascopubs.orgCategories: General Medicine News, Onc News and JournalsTweet-
Selection of Germline #GeneticTesting Panels in Patients with Cancer: @ASCO Guideline Clinical Insights https://t.co/dkhiMnQ3Mb
-
-
Mashup Score: 7Molecular Testing and Biomarkers - 8 month(s) ago
Molecular Testing and Biomarkers
Source: society.asco.orgCategories: General Medicine News, Partners & KOLsTweet-
Just issued: New guideline on selection of germline #GeneticTesting panels in patients with cancer. ➡️ https://t.co/5KitwI9pEO https://t.co/NiaLR2i2Yv
-
-
Mashup Score: 20Disparities in Genetic Testing for Neurologic Disorders - 10 month(s) ago
Dr. Stacey Clardy talks with Aaron Baldwin about how access to genetic testing may vary based on various factors such as race, ethnicity, sex, socioeconomic status, and insurance status. Read the related article in . Disclosures can be found at Neurology.org.
Source: directory.libsyn.comCategories: General Medicine News, NeurologyTweet-
Neurology Podcast: Drs. @StaceyLClardy & @aaron_baldwin discuss how access to #GeneticTesting may vary based on various factors such as race, ethnicity, sex, socioeconomic status & insurance status. Listen now: https://t.co/6FwD4IrpZw Read the article: https://t.co/D1UE1gdYUA https://t.co/qtM6rtqhSN
-
-
Mashup Score: 1De novo heterozygous missense variants in CELSR1 as cause of fetal pleural effusions and progressive fetal hydrops - PubMed - 10 month(s) ago
Fetal hydrops as detected by prenatal ultrasound usually carries a poor prognosis depending on the underlying aetiology. We describe the prenatal and postnatal clinical course of two unrelated female probands in whom de novo heterozygous missense variants in the planar cell polarity gene C …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, General Journals & SocietTweet-
🚼Catch up on the latest research linking CELSR1 variants to prenatal and postnatal traits! ▶️Evidence for pathogenicity of heterozygous CELSR1 deleterious missense variants as a potential cause for fetal hydrops 👀 👉 https://t.co/cxSOn1Slrb @LUMC_Leiden #genetictesting https://t.co/7Q4isv0chl
-
-
Mashup Score: 20High-Resolution and Noninvasive Fetal Exome Screening | NEJM - 1 year(s) ago
Correspondence from The New England Journal of Medicine — High-Resolution and Noninvasive Fetal Exome Screening
Source: www.nejm.orgCategories: General Medicine News, General HCPsTweet-
Researchers develop new method for prenatal #geneticTesting @nejm https://t.co/6JSGeOE1WM https://t.co/sN81pRmkpb
-
-
Mashup Score: 0
When a patient’s medications don’t work and have troubling side effects, will you know how to use genetic testing?
Source: www.medscape.orgCategories: Latest Headlines, PsychiatryTweet-
🖥️ When a patient's medications don't work and have troubling side effects, will you know how to use genetic testing? #MDD #PsychX #GeneticTesting #MedEd 📍 Learn and earn credit here: https://t.co/KeyIibHigL https://t.co/hsnEacJAFr
-
-
Mashup Score: 0
When a patient’s medications don’t work and have troubling side effects, will you know how to use genetic testing?
Source: www.medscape.orgCategories: Latest Headlines, PsychiatryTweet-
🖥️ When a patient's medications don't work and have troubling side effects, will you know how to use genetic testing? #MDD #PsychX #GeneticTesting #MedEd 📍 Learn and earn credit here: https://t.co/IHWnvtuXwu https://t.co/u4VD0Y6OIO
-
🎥 Episode 2 is here! Featuring experts from GeneDx, learn how to confidently appeal insurance denials for genetic testing. Missed Episode 1? Catch up now to Understand Your Insurance. 📺 Episode 1: https://t.co/vAnztk2xGg 📺 Episode 2: https://t.co/WjbSPUSY5A #genetictesting https://t.co/5F2okRB3iG